HLA-B57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B57:01-negative subjects
Small, Catherine Butkus, Margolis, David A, Shaefer, Mark S, Ross, Lisa L
Published in BMC infectious diseases (11.04.2017)
Published in BMC infectious diseases (11.04.2017)
Get full text
Journal Article
HLA-B57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA ® observational database: a cohort study
Mounzer, Karam, Hsu, Ricky, Fusco, Jennifer S, Brunet, Laurence, Henegar, Cassidy E, Vannappagari, Vani, Stainsby, Chris M, Shaefer, Mark S, Ragone, Leigh, Fusco, Gregory P
Published in AIDS research and therapy (16.01.2019)
Published in AIDS research and therapy (16.01.2019)
Get full text
Journal Article
Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min
Ross, Lisa L, Walker, A Sarah, Lou, Yu, Tenorio, Allan R, Gibb, Diana M, Double, Julia, Gilks, Charles, McCoig, Cynthia C, Munderi, Paula, Musoro, Godfrey, Kityo, Cissy M, Grosskurth, Heiner, Hakim, James, Mugyenyi, Peter N, Cutrell, Amy, Perger, Teodora, Shaefer, Mark S
Published in PloS one (14.11.2019)
Published in PloS one (14.11.2019)
Get full text
Journal Article
Early Virologic Nonresponse to Tenofovir, Abacavir, and Lamivudine in HIV-Infected Antiretroviral-Naive Subjects
Gallant, Joel E., Rodriguez, Allan E., Weinberg, Winkler G., Young, Benjamin, Berger, Daniel S., Lim, Michael L., Liao, Qiming, Ross, Lisa, Johnson, Judy, Shaefer, Mark S.
Published in The Journal of infectious diseases (01.12.2005)
Published in The Journal of infectious diseases (01.12.2005)
Get full text
Journal Article
Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial
Wohl, David A, Bhatti, Laveeza, Small, Catherine B, Edelstein, Howard, Zhao, Henry H, Margolis, David A, DeJesus, Edwin, Weinberg, Winkler G, Ross, Lisa L, Shaefer, Mark S
Published in PloS one (13.05.2014)
Published in PloS one (13.05.2014)
Get full text
Journal Article
HIV-1 transmission patterns in antiretroviral therapy-naïve, HIV-infected North Americans based on phylogenetic analysis by population level and ultra-deep DNA sequencing
Ross, Lisa L, Horton, Joseph, Hasan, Samiul, Brown, James R, Murphy, Daniel, DeJesus, Edwin, Potter, Martin, LaMarca, Anthony, Melendez-Rivera, Ivan, Ward, Douglas, Uy, Jonathon, Shaefer, Mark S
Published in PloS one (26.02.2014)
Published in PloS one (26.02.2014)
Get full text
Journal Article
Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States
Ross, Lisa L, Shortino, Denise, Shaefer, Mark S
Published in AIDS research and human retroviruses (01.08.2018)
Published in AIDS research and human retroviruses (01.08.2018)
Get more information
Journal Article
Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M)
Chounta, Vasiliki, Overton, Edgar T., Mills, Anthony, Swindells, Susan, Benn, Paul D., Vanveggel, Simon, van Solingen-Ristea, Rodica, Wang, Yuanyuan, Hudson, Krischan J., Shaefer, Mark S., Margolis, David A., Smith, Kimberly Y., Spreen, William R.
Published in The patient : patient-centered outcomes research (01.11.2021)
Published in The patient : patient-centered outcomes research (01.11.2021)
Get full text
Journal Article
To dose-adjust or not to dose-adjust: lamivudine dose in kidney impairment
Mounzer, Karam, Brunet, Laurence, Wyatt, Christina M., Fusco, Jennifer S., Vannappagari, Vani, Tenorio, Allan R., Shaefer, Mark S., Ragone, Leigh, Hsu, Ricky K., Fusco, Gregory P.
Published in AIDS (London) (01.07.2021)
Published in AIDS (London) (01.07.2021)
Get full text
Journal Article
Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/ emtricitabine with lopinavir/ritonavir for initial HIV treatment
SMITH, Kimberly Y, PATEL, Parul, WANNAMAKER, Paul, SHAEFER, Mark S, FINE, Derek, BELLOS, Nicholaos, SLOAN, Louis, LACKEY, Philip, KUMAR, Princy N, SUTHERLAND-PHILLIPS, Denise H, VAVRO, Cindy, LINDA YAU
Published in AIDS (London) (31.07.2009)
Published in AIDS (London) (31.07.2009)
Get full text
Journal Article
Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort
Mounzer, Karam C, Fusco, Jennifer S, Hsu, Ricky K, Brunet, Laurence, Vannappagari, Vani, Frost, Kevin R, Shaefer, Mark S, Rinehart, Alex, Rawlings, Keith, Fusco, Gregory P
Published in AIDS patient care and STDs (01.11.2021)
Published in AIDS patient care and STDs (01.11.2021)
Get more information
Journal Article
Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B5701 Screening as a Risk‐Mitigation Measure
Stainsby, Chris M., Perger, Teodora M., Vannappagari, Vani, Mounzer, Karam C., Hsu, Ricky K., Henegar, Cassidy E., Oyee, James, Urbaityte, Rimgaile, Lane, Charlotte E., Carter, Lindsay M., Pakes, Gary E., Shaefer, Mark S.
Published in Pharmacotherapy (01.01.2019)
Published in Pharmacotherapy (01.01.2019)
Get full text
Journal Article
A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)
Kumar, Princy N, Salvato, Patricia, LaMarca, Anthony, DeJesus, Edwin, Patel, Parul, McClernon, Daniel, Florance, Allison, Shaefer, Mark S
Published in AIDS research and therapy (09.04.2009)
Published in AIDS research and therapy (09.04.2009)
Get full text
Journal Article
Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir
Robertson, Kevin, Maruff, Paul, Ross, Lisa L., Wohl, David, Small, Catherine B, Edelstein, Howard, Shaefer, Mark S.
Published in Journal of neurovirology (01.02.2019)
Published in Journal of neurovirology (01.02.2019)
Get full text
Journal Article
Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patients
SQUIRES, Kathleen E, YOUNG, Benjamin, DEJESUS, Edwin, BELLOS, Nicholaos, MURPHY, Daniel, ZHAO, Henry H, PATEL, Lisa G, ROSS, Lisa L, WANNAMAKER, Paul G, SHAEFER, Mark S
Published in AIDS (London) (24.08.2010)
Published in AIDS (London) (24.08.2010)
Get full text
Journal Article
Long-term results of initial therapy with abacavir and Lamivudine combined with Efavirenz, Amprenavir/Ritonavir, or Stavudine
Bartlett, John A, Johnson, Judy, Herrera, Gisela, Sosa, Nestor, Rodriguez, Alan, Liao, Qiming, Griffith, Sandy, Irlbeck, David, Shaefer, Mark S
Published in Journal of acquired immune deficiency syndromes (1999) (01.11.2006)
Published in Journal of acquired immune deficiency syndromes (1999) (01.11.2006)
Get more information
Journal Article
Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES
Young, Benjamin, Squires, Kathleen E, Ross, Lisa L, Santiago, Lizette, Sloan, Louis M, Zhao, Henry H, Wine, Brian C, Pakes, Gary E, Margolis, David A, Shaefer, Mark S
Published in AIDS research and human retroviruses (01.02.2013)
Published in AIDS research and human retroviruses (01.02.2013)
Get more information
Journal Article
Twice-Daily Triple Nucleoside Intensification Treatment with Lamivudine-Zidovudine plus Abacavir Sustains Suppression of Human Immunodeficiency Virus Type 1: Results of the TARGET Study
Henry, Keith, Wallace, Robert J., Bellman, Paul C., Norris, Dorece, Fisher, Robin L., Ross, Lisa L., Liao, Qiming, Shaefer, Mark S.
Published in The Journal of infectious diseases (15.02.2001)
Published in The Journal of infectious diseases (15.02.2001)
Get full text
Journal Article
Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks
Squires, Kathleen E, Young, Benjamin, Santiago, Lizette, Dretler, Robin H, Walmsley, Sharon L, Zhao, Henry H, Pakes, Gary E, Ross, Lisa L, Shaefer, Mark S
Published in HIV/AIDS (Auckland) (01.01.2017)
Published in HIV/AIDS (Auckland) (01.01.2017)
Get full text
Journal Article